GFAP and Alzheimer disease: GFAP levels in the blood, instead, reflect neuroinflammation and have been found to be higher in Aβ-positive than in Aβ-negative people, and in individuals with AD or mild cognitive impairment (MCI) than in healthy controls (HC) [29].